About Apollo, Inc.
Apollo Endosurgery, Inc. was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 with the goal of advancing the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.
The Group conducted its first preclinical NOTES (Natural Orifice Translumenal Endoscopic Surgery) studies in 2001 and published its first NOTES literature in 2002. During that period, the Apollo Group’s efforts resulted in 17 issued patents, 35 applications in review and 130 disclosures.
In 2006, Apollo Endosurgery, Inc. was founded to commercialise the Group’s inventions and innovations in the areas of NOTES (Translumenal Surgery) and Therapeutic Endoscopy (Intralumenal Surgery). With the potential to benefit patients in a multitude of procedures, Apollo, Inc. is committed to the advancement of less invasive therapies through ongoing research and development, external partnerships, as well as relationships with key clinicians and the leading medical societies.
Along with the members of the Apollo Group, the Apollo corporate team is recognised globally as respected thought leaders in Therapeutic Endoscopy, clinical experts in trial testing design, innovators of new products and, as an engine for future commercial development of GI and minimally invasive products.
With sales and distribution on a global scale, Apollo, Inc is helping to foster in a new era of surgery worldwide.
For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.